Sociedad Americana de Hirudoterapia

Aeromonas hydrophila infections following clinical use of medicinal leeches: a review of published cases

Review published in Blood coagulation & fibrinolysis (1991)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewSeguridad y control de infeccionesLineaweaver WC et al. · Blood coagulation & fibrinolysis, 1991

Abstract

Ten Aeromonas hydrophila infections following postsurgical leech applications have been reported. These cases indicate that postsurgical wounds and damaged tissue can provide entry for either acute or delayed A. hydrophila infection. These infections can range from localized cellulitis to progressive myonecrosis and sepsis. These infections may occur with measurable frequency in groups of patients exposed to leeches. Based on this review, it is recommended that leeches be applied only to tissue with a reasonably certain arterial supply; that patients receive antibiotics against A. hydrophila prior to leech administration; and that consideration be given to prolonged antibiotic administration to patients discharged home with open wounds or questionably viable tissue after leech administration.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAeromonasAnimalsAnti-Bacterial AgentsBites and StingsGram-Negative Bacterial InfectionsHumansIncidenceLeechesPostoperative ComplicationsPremedication

Resumen

Aeromonas hydrophila infections following clinical use of medicinal leeches: a review of published cases.

Por qué esto importa para la hirudoterapia

This review examined ten reported cases of Aeromonas hydrophila infections following postsurgical leech applications. The abstract describes infections ranging from localized cellulitis to progressive myonecrosis and sepsis, and recommends that leeches be applied only to tissue with a reasonably certain arterial supply, that patients receive antibiotics against A. hydrophila prior to leech administration, and that prolonged antibiotic administration be considered for patients discharged with open wounds or questionably viable tissue. This article is relevant to the American Society of Hirudotherapy as it addresses clinical safety considerations and infectious complications associated with medical leeching, directly informing risk management in postsurgical leech therapy.

Citación

Aeromonas hydrophila infections following clinical use of medicinal leeches: a review of published cases

Lineaweaver WC et al. · Blood coagulation & fibrinolysis, 1991

DOIPubMed

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Safety ProtocolsAeromonas ManagementAeromonasHirudinDirect Thrombin InhibitorsAnticoagulation CompoundsHemostasisOtolaryngology

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.